improving the intelligence of your data ... - svmpharma · 1. ema seeking to make better use of...

2
For more on RWE visit: www.svmpharma.com 1. EMA seeking to make better use of patient registries to collect high- quality data on medicines 2. Big Data remains high on EU's healthcare agenda 3. Drive better decision making and gain Real World Insights with healthcare professional engagement RWE messages that you may have missed out on (Click on the links below to find out more) Improving the intelligence of your data capture: Technology in RWE CONTACT US [email protected] +44(0) 1252 417030 SVMPharma Limited www.svmpharma.com To read the article, continue onto the next page SVMPharma RWE projects are built on the strengths of: Knowing the RWE landscape Establishing connections with healthcare professionals and key opinion leaders Intelligent use of technology

Upload: others

Post on 22-Sep-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Improving the intelligence of your data ... - SVMPharma · 1. EMA seeking to make better use of patient registries to collect high-quality data on medicines 2. Big Data remains high

For more on RWE visit: www.svmpharma.com

1. EMA seeking to make better use of patient registries to collect high-quality data on medicines

2. Big Data remains high on EU's healthcare agenda

3. Drive better decision making and gain Real World Insights with healthcare professional engagement

RWE messages that you may have missed out on(Click on the links below to find out more)

Improving the intelligence of your data capture: Technology in RWE

CONTACT US [email protected]

+44(0) 1252 417030SVMPharma Limited

www.svmpharma.com

To read the article, continue onto the next page

SVMPharma RWE projects are built on the strengths of:• Knowing the RWE landscape• Establishing connections with

healthcare professionals and key opinion leaders

• Intelligent use of technology

Page 2: Improving the intelligence of your data ... - SVMPharma · 1. EMA seeking to make better use of patient registries to collect high-quality data on medicines 2. Big Data remains high

The rise of real world data has beenfacilitated by advances in digitaltechnology and eHealth infrastructuresthat are able to track and documentpatients and their health. The growth ofRWD use in HTA assessments make theaccuracy and validity of electronic dataa priority issue for real world evidence.

The convenience of edata sourcesshould be weighed up against anassessment of the quality of the data.In addition to not being widely availablewithin the UK, edatabases such asthose holding prescribing data are notroutinely audited, therefore requiresvalidity testing and normalisation.

As part of the process of data capture,SVMPharma’s eCRF, the Real WorldEvidence Treatment Evaluator, makessense of large amounts of structureddata by a process of normalisation andfilling data gaps. This validation drivesmore meaningful outputs from thedata.

In-house development means yourRWE Treatment Evaluator is bespokeand cost effective, whilst still deliveringfast, efficient, reliable, secure, andcompliant data capture enabled byeCRFs.

As part of our global technologyplatform, smart data dashboards orpredictive analytics tools can be builtinto the RWE Treatment Evaluator,creating a truly all encompassingtechnology solution to deliver thesuperior data and the outcomes thatmatter to your brand.

CONTACT US [email protected]

+44(0) 1252 417030SVMPharma Limited

www.svmpharma.com

Improving the intelligence of your data capture: Technology in RWE

The type of data and its source should always be a consideration when capturingdata. Making sense of electronic data sources is easy with electronic data capturesystems that normalise and validate data input to ensure consistent data, identifyand organise data gaps, and deliver reliable and insightful outputs.

“Electronic registries and databases are one prominent technology that can be utilised, but smart electronic

data capture systems have been putting the power directly in the

hands of healthcare professionals and researchers”.